Utility of Inflammatory Biomarkers in Patients with Covid-19 Infections: Bahrain Experience
Eman Farid, Kannan Sridharan, Ola Al-Segai, Safa Al Khawaja, Eman J. Mansoor, Noor Al Teraifi, Manaf Al Qahtani, Jameela Al Salman
Abstract
We observed serum ferritin, D-dimer and CRP to accurately predict patients developing severe COVID-19 infections as well as those at risk of developing COVID pneumonia. A trend in IL-6 levels was observed in patients on tocilizumab therapy.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicinePandemicCoronavirus InfectionsBetacoronavirusVirologyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research